U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Stage IIA Testicular Cancer AJCC v6 and v7

MedGen UID:
1639607
Concept ID:
C4552014
Neoplastic Process
Synonyms: Stage IIA Cancer of Testis; Stage IIA Cancer of the Testis; Stage IIA Testicular Cancer; Stage IIA Testicular Cancer AJCC v6; Stage IIA Testicular Cancer AJCC v7

Definition

Stage IIA includes: (Any pT/TX, N1, M0, S0); (Any pT/TX, N1, M0, S1). pTX: Primary tumor cannot be assessed. N1: Metastasis with a lymph node mass 2 cm or less in greatest dimension; or multiple lymph nodes, none more than 2cm in greatest dimension. M0: No distant metastasis. S0: Marker study levels within normal limits. S1: LDH less than 1.5 x N (N indicates the upper limit of normal for the LDH assay) and hCG less than 5,000 and AFP less than 1,000. (AJCC 6th and 7th eds.) [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVStage IIA Testicular Cancer AJCC v6 and v7

Supplemental Content

Table of contents

    Recent activity

    • Stage IIA Testicular Cancer AJCC v6 and v7
      Stage IIA Testicular Cancer AJCC v6 and v7
      MedGen
    • Insulinoma tumor suppressor gene locus
      Insulinoma tumor suppressor gene locus
      MedGen
    • Paroxysmal Hemicrania
      Paroxysmal Hemicrania
      A primary headache disorder that is similar to the CLUSTER HEADACHE with unilateral head pain, but differs by its multiple short severe attacks. It is usually seen in females,...<br/>Year introduced: 2006
      MeSH
    • Migraine Disorders
      Migraine Disorders
      A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and class...<br/>Year introduced: 2006 (1963)
      MeSH
    • Retinal capillary hemangioma
      Retinal capillary hemangioma
      MedGen

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...